Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Title-Recordkeeping for the Transfer of Electronic Prescriptions in Schedules III-V Between Pharmacies
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Drug Enforcement Administration, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the Federal Register, volume 91 FR 46484, on July 23, 2026, allowing a 60-day comment period.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 189 (Thursday, October 1, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 189 (Thursday, October 1, 2026)]
[Notices]
[Pages 62560-62561]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-20115]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0061]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Revision of a Previously Approved Collection;
Title--Recordkeeping for the Transfer of Electronic Prescriptions in
Schedules III-V Between Pharmacies
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-day Notice.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration, Department of Justice
(DOJ), will be submitting the following information collection request
to the Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. The proposed
information collection was previously published in the Federal
Register, volume 91 FR 46484, on July 23, 2026, allowing a 60-day
comment period.
DATES: Comments are encouraged and will be accepted for 30 days until
November 2, 2026.
FOR FURTHER INFORMATION CONTACT: If you have comments especially on the
estimated public burden or associated response time, suggestions, or
need a copy of the proposed information collection instrument with
instructions or additional information, please contact: Heather E.
Achbach, Regulatory Drafting and Policy Support Section, Drug
Enforcement Administration; Mailing Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone: (571) 776-3882; Email:
<a href="/cdn-cgi/l/email-protection#97d3d2d6b9c7c5d6d7f3f2f6b9f0f8e1"><span class="__cf_email__" data-cfemail="e6a2a3a7c8b6b4a7a6828387c8818990">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be
collected; and/or
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Written comments and recommendations for this information
collection should be submitted within
[[Page 62561]]
30 days of the publication of this notice on the following website
<a href="http://www.reginfo.gov/public/do/">www.reginfo.gov/public/do/</a>PRAMain. Find this particular information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function and entering either
the title of the information collection or the OMB Control Number 1117-
0061. This information collection request may be viewed at
<a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view Department of Justice,
information collections currently under review by OMB. If submitting a
comment, please send a copy of your comment to Heather Achbach to
<a href="/cdn-cgi/l/email-protection#8dc9c8cca3dddfcccde9e8eca3eae2fb"><span class="__cf_email__" data-cfemail="a8ecede986f8fae9e8cccdc986cfc7de">[email protected]</span></a>.
DOJ seeks PRA authorization for this information collection for
three (3) years. OMB authorization for an ICR cannot be for more than
three (3) years without renewal. The DOJ notes that information
collection requirements submitted to the OMB for existing ICRs receive
a month-to-month extension while they undergo review.
Abstract: This information collection requires the transferring
pharmacy to update the electronic prescription record to note that the
prescription was transferred, and to add the following information: the
name, address, and DEA registration number of the pharmacy to which the
prescription was transferred; the name of the pharmacist receiving the
transfer; the name of the transferring pharmacist; and the date of the
transfer. The pharmacy receiving the transfer is required to update the
electronic prescription record with the name, address, and DEA
registration number of the pharmacy transferring the prescription, the
name of the transferring pharmacist, the name of the pharmacist
receiving the transfer, and the date of the transfer.
Overview of This Information Collection
1. Type of Information Collection: Extension of a previously
approved collection.
2. Title of the Form/Collection: Recordkeeping for the Transfer of
Electronic Prescriptions for Controlled Substances in Schedules II-V
between Pharmacies for Initial Filling.
3. Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection: No form number is
associated with this collection. The applicable component within the
Department of Justice is the Drug Enforcement Administration, Diversion
Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract: Affected Public: (Primary) Business or other
for-profit.
5. Obligation to Respond: Mandatory, 21 U.S.C. 827 and 958.
6. Total Estimated Number of Respondents: The DEA estimates that
66,088 registrants participate in this information collection.
7. Estimated Time per Respondent: The time per response is 3
minutes for the recordkeeping.
8. Frequency: As needed, Annual.
9. Total Estimated Annual Time Burden: 645,000 hours.
10. Total Estimated Annual Other Costs Burden: $0.
----------------------------------------------------------------------------------------------------------------
Time per
Activity Number of Frequency Total annual response Total annual
respondents responses (hours) burden (hours)
----------------------------------------------------------------------------------------------------------------
Transfer of EPCS................ 66,088 195.19429 12,900,000 0.05 645,000
-------------------------------------------------------------------------------
Unduplicated Totals......... 66,088 0 12,900,000 0.05 645,000
----------------------------------------------------------------------------------------------------------------
If additional information is required, contact: Darwin Arceo,
Department Clearance Officer, Enterprise Portfolio Management, Justice
Management Division, United States Department of Justice, Two
Constitution Square, 145 N Street NE, 4W-218, Washington, DC 20530.
Dated: September 29, 2026.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2026-20115 Filed 9-30-26; 8:45 am]
BILLING CODE 4410-09-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.